NYUHSL Faculty Bibliography

Searched for:

in-biosketch:true

person:tanejs01

Total Results:

832

Journal of urology. 2014:191(3).DOI: 10.1016/j.juro.2013.11.085

Re: docetaxel and atrasentan versus docetaxel and placebo for men with advanced castration-resistant prostate cancer (SWOG S0421): a randomised phase 3 trial [Editorial]

Taneja, Samir S

PMID: 24522033

ISSN: 0022-5347

CID: 951942

Journal of urology. 2014:191(3).DOI: 10.1016/j.juro.2013.11.088

Re: plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial [Comment]

Taneja, Samir S

PMID: 24522035

ISSN: 0022-5347

CID: 951962

Journal of urology. 2014:191(2).DOI: 10.1016/j.juro.2013.11.015

Re: Pathological and Oncologic Outcomes for Men with Positive Lymph Nodes at Radical Prostatectomy: The Johns Hopkins Hospital 30-Year Experience

Taneja, Samir S

PMID: 24411856

ISSN: 0022-5347

CID: 763662

Journal of urology. 2014:191(2).DOI: 10.1016/j.juro.2013.11.010

Re: long-term survival of participants in the prostate cancer prevention trial

Taneja, Samir S

PMID: 24411850

ISSN: 0022-5347

CID: 763692

Journal of urology. 2014:191(2).DOI: 10.1016/j.juro.2013.11.014

Re: Empiric Antibiotics for an Elevated Prostate-Specific Antigen (PSA) Level: A Randomised, Prospective, Controlled Multi-Institutional Trial

Taneja, Samir S

PMID: 24411853

ISSN: 0022-5347

CID: 763682

Urologic clinics of North America. 2014:41(1).DOI: 10.1016/j.ucl.2013.10.001

Current management of male infertility [Editorial]

Taneja, Samir S

PMID: 24286779

ISSN: 0094-0143

CID: 666302

Journal of urology. 2014:191(2).DOI: 10.1016/j.juro.2013.11.013

Re: The Prostate Cancer Prevention Trial Risk Calculator and the Relationship between Prostate-Specific Antigen and Biopsy Outcome

Taneja, Samir S

PMID: 24411854

ISSN: 0022-5347

CID: 763672

European journal of radiology. 2014:83(2):239-44.DOI: 10.1016/j.ejrad.2013.10.020

Impact of size of region-of-interest on differentiation of renal cell carcinoma and renal cysts on multi-phase CT: Preliminary findings

Rosenkrantz, Andrew B; Matza, Brent W; Portnoy, Elie; Melamed, Jonathan; Taneja, Samir S; Wehrli, Natasha E

INTRODUCTION: To assess impact of size of regions-of-interest (ROI) on differentiation of RCC and renal cysts using multi-phase CT, with focus on differentiating papillary RCC (pRCC) and cysts given known hypovascularity of pRCC. METHODS: 99 renal lesions (23 pRCC, 47 clear-cell RCC, 7 chromophobe RCC, 22 cysts) underwent multi-phase CT. Subjective presence of visual enhancement was recorded for each lesion. Whole-lesion (WL) ROIs, and small (

PMID: 24239241

ISSN: 0720-048x

CID: 666882

Journal of urology. 2014:191(1):75-75.DOI:

Re: Strategy for Detection of Prostate Cancer Based on Relation between Prostate Specific Antigen at Age 40-55 and Long Term Risk of Metastasis: Case-Control Study Editorial Comment [Editorial]

Taneja, Samir S

ISI:000329191700027

ISSN: 1527-3792

CID: 1877242

Journal of urology. 2014:191(1):75-6.DOI: 10.1016/j.juro.2013.09.081

Re: Urinary TMPRSS2:ERG and PCA3 in an Active Surveillance Cohort: Results from a Baseline Analysis in the Canary Prostate Active Surveillance Study

Taneja, Samir S

PMID: 24331481

ISSN: 0022-5347

CID: 763722